Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic value of cell-free DNA in thyroid cancer: A systematic review and meta-analysis.

Medicine - 17 Feb 2023

Hou Fei, Sun Xiao-Dan, Deng Zhi-Yong

Abstract excerpt

OBJECTIVE: An increasing number of studies have shown the potential diagnostic value of cell-free DNA (cfDNA) as a new biomarker in the management of thyroid cancer (TC); however, the accuracy of research results is inconsistent. This meta-analysis is the first to synthesize published results and evaluate the application value of circulating cfDNA in the diagnosis of TC. METHODS: A search strategy was developed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cell-Free Nucleic Acids
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ROC Curve

Share to Sensitivity and Specificity

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 36800605
DOI: 10.1097/MD.0000000000032928
PMCID: PMC9935987

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic value of cell-free DNA in thyroid cancer: A systematic review and meta-analysis.PMID 36800605Read ↗

Evaluating the prognostic potential of circulating cell-free DNA in advanced thyroid cancer.Semantic proximity Read ↗

Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinomaSemantic proximity Read ↗

Facilitation of Definitive Cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With Thyroid Nodules.Semantic proximity Read ↗

The Diagnostic Value of BRAF V600E Gene Detection Combined with DNA Ploidy Analysis in Thyroid Cancer.Semantic proximity Read ↗

IS MEASUREMENT OF CIRCULATING TUMOR DNA OF DIAGNOSTIC USE IN PATIENTS WITH THYROID NODULES?Semantic proximity Read ↗

Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid Carcinoma.Semantic proximity Read ↗

Characterization of the Thyroid Cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing.Semantic proximity Read ↗

Tumor-informed liquid biopsy for monitoring thyroid cancer: a proof-of-concept study.Semantic proximity Read ↗

The value of Korean, American, and Chinese ultrasound risk stratification systems combined with BRAF(V600E) mutation for detecting papillary thyroid carcinoma in cytologically indeterminate thyroid nodules.Semantic proximity Read ↗

[Diagnostic Value of American Thyroid Association Guidelines,American College of Radiology Thyroid Imaging Reporting and Data System,and Chinese Thyroid Imaging Reporting and Data System Alone and Combined With BRAFV600E Mutation in Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance].Semantic proximity Read ↗

Current Trends in Cell-Free DNA Applications. Scoping Review of Clinical TrialsSemantic proximity Read ↗

CirculatingBRAFV600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.